In treating rheumatic diseases, 4 members of the Janus kinases family (JAK1, JAK2, JAK3, and tyrosine kinase-2; TYK2) and their 7 downstream signal transducers and activators of transcription (STATs) are currently of greatest interest. Here, TYK2 is linked to rheumatic disorder.